Who Paid My Doc
Baha Sibai
Maternal & Fetal Medicine Houston, TX Medical Doctor
NPI 1942381926 CMS profile 133378
6410 Fannin St Ste 360, Houston, TX 77030
General payments
$131,735
Research payments
$1,694
Ownership & investment interest
$0
Research they led as principal investigator
$703,822
Through program year 2025, Baha Sibai of Houston, TX is reported in the CMS Open Payments database as having received $131,735 across 85 general payments and $1,694 in research payments paid to them. Separately, studies naming them as principal investigator received $703,822 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Maternal & Fetal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $6,907 | 8 | |
| 2023 | General | $8,327 | 6 | |
| 2022 | General | $42,533 | 11 | |
| 2020 | General | $23,293 | 8 | |
| 2019 | General | $50,675 | 52 | |
| 2019 | Research | $1,694 | 11 |
Beside peers
- Baha Sibai
- Maternal & Fetal Medicine median
- Middle half of Maternal & Fetal Medicine
- National median
In program year 2025, general payments to Baha Sibai were reported at $6,907. Among 891 Maternal & Fetal Medicine profiles paid that year, the median was $56 and the middle half received between $25 and $146.
Show as a table
| Year | Baha Sibai | Maternal & Fetal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $50,675 | $70 | $23–$148 | $163 |
| 2020 | $23,293 | $51 | $18–$141 | $114 |
| 2021 | $0 | $43 | $20–$137 | $132 |
| 2022 | $42,533 | $48 | $22–$145 | $149 |
| 2023 | $8,327 | $53 | $24–$150 | $160 |
| 2024 | $0 | $68 | $25–$159 | $164 |
| 2025 | $6,907 | $56 | $25–$146 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
96 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Maternal & Fetal Medicine in Texas
George Saade
Maternal & Fetal Medicine · Galveston, TX
Jimmy Espinoza
Maternal & Fetal Medicine · Houston, TX
Kevin Magee
Maternal & Fetal Medicine · Dallas, TX
Kenneth Moise
Maternal & Fetal Medicine · Austin, TX
Sean Blackwell
Maternal & Fetal Medicine · Houston, TX
Saul Snowise
Maternal & Fetal Medicine · Houston, TX
Related records
Maternal & Fetal Medicine in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Maternal & Fetal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.